Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dendrobium Huoshanense Granules in Rectal Cancer NCRT
NCT04394598Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Mar 2020
- Primary completion
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes, Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dendrobium huoshanense in rectal cancer, sponsored by Fudan University. Status: unknown.
02
Drugs
dendrobium huoshanense
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT04394598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04394598.